Pioglitazone
What is Pioglitazone?
Pioglitazone (CAS 111025-46-8) is an oral antidiabetic active pharmaceutical ingredient of the thiazolidinedione class.
Where is Pioglitazone used?
- Type 2 diabetes: insulin sensitizer targeting peripheral tissue resistance
- Solid dosage form development: finished API for pharmaceutical manufacturers
- Tablet formulations: reduces insulin resistance in muscle and adipose tissue
- Monotherapy and fixed-dose combination tablets alongside metformin or glimepiride
- Synthesis research and formulation development pipelines for metabolic disease indications
- CDMOs source it for bioequivalence study batches and commercial-scale tablet production.
Good to know: The hydrochloride salt form is the predominant commercial grade used in finished dosage manufacturing. It works without stimulating pancreatic insulin secretion.
Commercial specifications
- Pharmaceutical-grade specifications, including USP and Ph. Eur. compliant material
- Bulk API in kilogram to multi-kilogram quantities
- CoA, DMF references, and ICH-compliant impurity profiling
Other Names (Synonyms)
5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione|5-({4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl}methyl)thiazolidine-2,4-dione|(+-)-5-({4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl}methyl)-2,4-thiazolidinedione|Glustin|Zactos|5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione|2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-